Pediatrix Medical Group (NYSE:MD) Trading Down 3.5% Following Insider Selling

Pediatrix Medical Group, Inc. (NYSE:MD) shares traded down 3.5% during mid-day trading on Thursday after an insider sold shares in the company. The company traded as low as $22.14 and last traded at $21.7650. 42,312 shares were traded during mid-day trading, a decline of 95% from the average session volume of 803,766 shares. The stock had previously closed at $22.56.

Specifically, CEO Mark S. Ordan sold 23,000 shares of the company’s stock in a transaction on Monday, December 15th. The stock was sold at an average price of $22.41, for a total value of $515,430.00. Following the sale, the chief executive officer directly owned 302,805 shares of the company’s stock, valued at $6,785,860.05. This represents a 7.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Analyst Upgrades and Downgrades

MD has been the topic of a number of recent research reports. Zacks Research upgraded shares of Pediatrix Medical Group from a “hold” rating to a “strong-buy” rating in a report on Friday, November 21st. Weiss Ratings reissued a “hold (c+)” rating on shares of Pediatrix Medical Group in a report on Monday. Leerink Partners raised their target price on Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a research report on Friday, September 5th. Wall Street Zen raised shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 4th. Finally, UBS Group raised their price objective on Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $21.00.

Pediatrix Medical Group Trading Up 1.2%

The stock has a market cap of $1.88 billion, a P/E ratio of 11.53 and a beta of 0.77. The stock’s 50-day moving average is $20.96 and its two-hundred day moving average is $17.01. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.83 and a quick ratio of 1.83.

Pediatrix Medical Group (NYSE:MD) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.46 by $0.21. The business had revenue of $492.88 million during the quarter, compared to the consensus estimate of $476.45 million. Pediatrix Medical Group had a net margin of 8.44% and a return on equity of 20.45%. The business’s revenue was down 3.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.44 EPS. Equities research analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the company. Marshall & Sullivan Inc. WA bought a new stake in shares of Pediatrix Medical Group in the 2nd quarter worth about $41,000. Canada Pension Plan Investment Board bought a new stake in Pediatrix Medical Group in the second quarter worth about $83,000. AlphaQuest LLC boosted its position in shares of Pediatrix Medical Group by 16.0% during the first quarter. AlphaQuest LLC now owns 5,877 shares of the company’s stock valued at $85,000 after buying an additional 811 shares during the period. Quantbot Technologies LP purchased a new position in shares of Pediatrix Medical Group during the second quarter valued at approximately $99,000. Finally, Smartleaf Asset Management LLC grew its stake in shares of Pediatrix Medical Group by 10.6% during the third quarter. Smartleaf Asset Management LLC now owns 6,250 shares of the company’s stock valued at $101,000 after buying an additional 601 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.